Literature DB >> 15335118

Hyposensitization therapy reduced exhaled nitric oxide in asthmatic children with corticosteroid dependency.

Chih-Hsing Hung1, Ming-Yung Lee, Yi-Giien Tsai, Shin-Nan Cheng, Kuender D Yang.   

Abstract

Measurement of exhaled nitric oxide (FeNO) is a simple and noninvasive method for assessment of airway inflammation severity in asthmatic patients. The aim of this study was to investigate whether hyposensitization with extracts of Dermatophagoides pteronyssinus (Der p) and Dermatophagoides farinae (Der f) could decrease airway inflammation as determined by FeNO levels. Ten asthmatic children with corticosteroid dependency were recruited for the study. Eight subjects completed a ten months mite hyposensitization regimen. FeNO concentrations, asthma symptom scores and peak expiratory flow rates (PEFR) were measured monthly before and after treatment. FeNO levels from asthmatic patients were found to be higher before treatment (65.34+/-31.63 ppb). FeNO levels fell significantly after four months' treatment (39.89+/-21.13 ppb; p<0.05). PEFR increased significantly five months after hyposensitization treatment (214.38+/-49.38 vs 251.25+/-28.00; p<0.05). Asthma symptom scores decreased 5 months after hyposensitization treatment (6.84+/-1.22 vs 5.80+/-0.67, p<0.05). Hyposensitization with extracts of Der p and Der f appears to improve clinical symptoms and reduce airway inflammation as determined by FeNO concentrations in children with mite allergy asthma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15335118

Source DB:  PubMed          Journal:  Acta Paediatr Taiwan        ISSN: 1608-8115


  2 in total

Review 1.  Mite immunotherapy.

Authors:  Enrique Fernández-Caldas; Victor Iraola; Manuel Boquete; Antonio Nieto; Miguel Casanovas
Journal:  Curr Allergy Asthma Rep       Date:  2006-09       Impact factor: 4.806

2.  Effects of specific allergen immunotherapy on biological markers and clinical parameters in asthmatic children: a controlled-real life study.

Authors:  I Djuric-Filipovic; Marco Caminati; D Filipovic; C Salvottini; Z Zivkovic
Journal:  Clin Mol Allergy       Date:  2017-04-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.